Recently, in a study in which 150 NSCLC patients with ALK mutations were enrolled, ctDNA levels, which declined post-surgery and exhibited deviations within 7 months after surgery, were also associated with higher risk of relapse [61]. Here, ALK is linked to non-small cell lung carcinoma.